VelosBio Inc. is a next-generation oncology company, developing novel antibody-drug conjugates (“ADCs”) to treat haematological cancers and solid tumours. ARIX BIOSCIENCE About Arix The Team Portfolio Insights News & Events Contact INVESTOR RELATIONS Results Centre Financial Calendar Regulatory News Document Library Analysts & Advisors Shareholder Information META Privacy Policy Terms of use Cookie Policy STAY UP TO DATE Sign up to receive regulatory news and results SUBSCRIBE Arix Bioscience plc, registered in England and Wales with company number 09777975 Registered office: Duke Street House, 50 Duke Street, London, W1K 6JL, United Kingdom Website by Ether